Increase/Decrease in Cash: The total change in cash for the company over the given period.
Silo Pharma, Inc. (SILO) had Increase/Decrease in Cash of $0.84M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.07M |
|
$-4.23M |
|
$0.04M |
|
$0.03M |
|
$4.35M |
|
$-4.28M |
|
$0.05M |
|
$-4.23M |
|
$-4.23M |
|
$-4.23M |
|
$-4.23M |
|
$-4.23M |
|
$-4.23M |
|
$-4.28M |
|
$-4.27M |
|
8.38M |
|
8.38M |
|
$-0.50 |
|
$-0.50 |
|
| Balance Sheet Financials | |
$7.39M |
|
-- |
|
$0.22M |
|
$7.61M |
|
$0.65M |
|
-- |
|
$0.65M |
|
$1.30M |
|
$6.31M |
|
$6.09M |
|
$6.31M |
|
13.32M |
|
| Cash Flow Statement Financials | |
$-4.66M |
|
$0.64M |
|
$4.86M |
|
$3.91M |
|
$4.75M |
|
|
Increase/Decrease in Cash |
$0.84M |
$0.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
38.57% |
|
-5936.95% |
|
-5936.95% |
|
-5921.09% |
|
-5863.50% |
|
-5863.50% |
|
$-4.66M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-67.05% |
|
-69.44% |
|
-55.59% |
|
-67.05% |
|
$0.47 |
|
$-0.56 |
|
$-0.56 |
|